MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,700.00
+30.00 (1.80%)
At close: Aug 22, 2025, 3:30 PM KST

MEDIZEN HUMANCARE Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2014FY 2013
Period Ending
Dec '14 Dec '13
583.8895.39
Revenue Growth (YoY)
512.09%-
Cost of Revenue
225.3148.58
Gross Profit
358.5746.81
Selling, General & Admin
1,200636.98
Research & Development
234.67478.88
Other Operating Expenses
21.696.82
Operating Expenses
2,0071,171
Operating Income
-1,648-1,124
Interest Expense
-48.4-35.31
Interest & Investment Income
8.910.24
Other Non Operating Income (Expenses)
1.69-0.07
EBT Excluding Unusual Items
-1,686-1,159
Other Unusual Items
--0.89
Pretax Income
-1,686-1,160
Net Income
-1,686-1,160
Net Income to Common
-1,686-1,160
Shares Outstanding (Basic)
22
Shares Outstanding (Diluted)
22
Shares Change (YoY)
32.09%-
EPS (Basic)
-821.00-746.00
EPS (Diluted)
-821.00-746.00
Free Cash Flow
-2,233-1,302
Free Cash Flow Per Share
-1086.98-837.23
Gross Margin
61.41%49.07%
Operating Margin
-282.33%-1178.21%
Profit Margin
-288.80%-1215.99%
Free Cash Flow Margin
-382.36%-1364.69%
EBITDA
-1,098-889.22
EBITDA Margin
-188.10%-
D&A For EBITDA
550.16234.68
EBIT
-1,648-1,124
EBIT Margin
-282.33%-
Advertising Expenses
37.4313.46
Source: S&P Global Market Intelligence. Standard template. Financial Sources.